Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.

Opioid bill heads to President Trump...

Senate Clears Opioid Bill With Partial IMD Repeal, FDA Labeling Authorities

October 04, 2018
The Senate cleared a massive bicameral package of opioid legislation on Wednesday (Oct. 3) by a vote of 98-1, with Sen. Mike Lee (R-UT) as the sole "no" vote, and Sen. Ted Cruz (R-TX) not voting. The package aims to stem the opioid crisis through myriad bipartisan provisions that affect FDA and CMS, among other federal agencies. The package includes measures to partially repeal a prohibition on Medicaid paying for treatment at certain inpatient facilities, expand access to addiction treatment,...